Cargando…

Structure‐Activity Relationship and Mode‐Of‐Action Studies Highlight 1‐(4‐Biphenylylmethyl)‐1H‐imidazole‐Derived Small Molecules as Potent CYP121 Inhibitors

CYP121 of Mycobacterium tuberculosis (Mtb) is an essential target for the development of novel potent drugs against tuberculosis (TB). Besides known antifungal azoles, further compounds of the azole class were recently identified as CYP121 inhibitors with antimycobacterial activity. Herein, we repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walter, Isabell, Adam, Sebastian, Gentilini, Maria Virginia, Kany, Andreas M., Brengel, Christian, Thomann, Andreas, Sparwasser, Tim, Köhnke, Jesko, Hartmann, Rolf W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519103/ https://www.ncbi.nlm.nih.gov/pubmed/34010508 http://dx.doi.org/10.1002/cmdc.202100283

Ejemplares similares

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors
por: Kishk, Safaa M., et al.
Publicado: (2019)

Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of Mycobacterium tuberculosis
por: Bajrai, Leena Hussein, et al.
Publicado: (2022)

Substrate‐Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors
por: Kaya, Cansu, et al.
Publicado: (2021)

Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis
por: Kumar, Amit, et al.
Publicado: (2021)

Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

(19)F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis
por: Campomizzi, Christopher S., et al.
Publicado: (2021)

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1
por: Kishk, Safaa M., et al.
Publicado: (2019)

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors
por: Alshabani, Lama A., et al.
Publicado: (2022)

Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases
por: Schönauer, Esther, et al.
Publicado: (2017)

Crystal structure of 4-methylsulfanyl-2-(2H-tetrazol-2-yl)pyrimidine
por: Thomann, Andreas, et al.
Publicado: (2015)

ANSYS Tutorial: Release 12.1, Structural and thermal analysis using the ANSYS release 12.1 environment
por: Lawrence, Kent L
Publicado: (2010)

Half-lives of $^{121}$Cs and $^{121}$In isomers
por: Scheidemann, Ø, et al.
Publicado: (1974)

Clotrimazole, an Imidazole Antimycotic, Is a Potent Inhibitor of Angiogenesis
por: Takahashi, Hiroto, et al.
Publicado: (1998)

N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium Collagenases
por: Konstantinović, Jelena, et al.
Publicado: (2020)

MSA1.2.1 - EMI Reference Releases
Publicado: (Octo)

Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation
por: Taban, Ismail M., et al.
Publicado: (2017)

1-deoxy-D-xylulose-5-phosphate synthase from Pseudomonas aeruginosa and Klebsiella pneumoniae reveals conformational changes upon cofactor binding
por: Hamid, Rawia, et al.
Publicado: (2023)

Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription
por: Madigan, Victoria J., et al.
Publicado: (2019)

Memorandum 121
por: Barloutaud, R
Publicado: (1978)

DNA1.2.1 - Service Level Agreement Template
Publicado: (June)

Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata
por: Badal, Simone, et al.
Publicado: (2012)

The decay of /sup 121/Xe (/sup 121/I deduced levels)
por: Münnich, F, et al.
Publicado: (1972)

3-Pyridyl Substituted Aliphatic Cycles as CYP11B2 Inhibitors: Aromaticity Abolishment of the Core Significantly Increased Selectivity over CYP1A2
por: Yin, Lina, et al.
Publicado: (2012)

Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting Mycobacterium tuberculosis CYP121
por: Hudson, Sean A., et al.
Publicado: (2013)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

The decay of $^{121}$Xe
por: Münnich, F, et al.
Publicado: (1972)

Optical Modulation of Antibiotic Resistance by Photoswitchable Cystobactamids
por: Testolin, Giambattista, et al.
Publicado: (2022)

2-[(1H-Imidazol-2-yl)disulfanyl]-1H-imidazole
por: Feizbakhsh Bazargani, Mona, et al.
Publicado: (2011)

12.1 CELL-SUBTYPE SPECIFIC BIOENERGETIC DEFECTS IN SCHIZOPHRENIA
por: Sullivan, Courtney, et al.
Publicado: (2018)

Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity
por: Bekier, Adrian, et al.
Publicado: (2021)

DJRA1.2.1 – Data Area Work Plan and Status Report
Publicado: (July)

Potent and Selective Inhibition of CYP1A2 Enzyme by Obtusifolin and Its Chemopreventive Effects
por: Park, Eun-Ji, et al.
Publicado: (2022)

Tris[2-(1H-imidazol-2-yl)imidazol-1-ido]cobalt(III)
por: Ma, Qi, et al.
Publicado: (2010)

4-[4-(1H-Imidazol-4-yl)phenyl]-1H-imidazole
por: Wang, Qian, et al.
Publicado: (2012)

Tourette syndrome research highlights from 2017
por: Hartmann, Andreas, et al.
Publicado: (2018)

Tourette syndrome research highlights from 2019
por: Hartmann, Andreas, et al.
Publicado: (2020)

121st LHCC Meeting
Publicado: (2015)

121st SPSC Meeting
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0pob4fpa4257l165068hbaeo0c